TransMedics Group, Inc. Common Stock (TMDX) — Analysis Summary
TransMedics Group, Inc. Common Stock (TMDX) has a market cap of $2.32B with year-over-year revenue growth of +37.1%. Net margin stands at 31.4%. The stock trades at a P/E ratio of 13.5.
Key Takeaways
- Revenue changed +37.1% year-over-year
- Net margin of 31.4%
- P/E ratio of 13.5
Compared to other companies in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector, TMDX posted revenue growth of +37.1% and trades at a P/E of 13.5.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.